APA Citatie

Ahn, M., Kim, S., Cho, B., Ahn, J. S., Lee, D. H., Sun, J., . . . Park, K. (2014). Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press.

Chicago Style citaat

Ahn, Myung-Ju, et al. Phase II Study of Afatinib As Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press, 2014.

MLA citatie

Ahn, Myung-Ju, et al. Phase II Study of Afatinib As Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR. AlphaMed Press, 2014.